Scholar Rock (SRRK) Competitors

Scholar Rock (NASDAQ:SRRK) and Viatris (NASDAQ:VTRS) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.

Which has more risk & volatility, SRRK or VTRS?

Scholar Rock has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Viatris has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Which has higher earnings and valuation, SRRK or VTRS?

Viatris has higher revenue and earnings than Scholar Rock. Viatris is trading at a lower price-to-earnings ratio than Scholar Rock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scholar Rock	$33.19M	84.89	-$165.79M	-$2.45	-12.15
Viatris	$14.74B	0.60	$54.70M	-$0.53	-13.94

Does the media prefer SRRK or VTRS?

In the previous week, Viatris had 50 more articles in the media than Scholar Rock. MarketBeat recorded 54 mentions for Viatris and 4 mentions for Scholar Rock. Scholar Rock's average media sentiment score of 1.33 beat Viatris' score of 0.02 indicating that Scholar Rock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Scholar Rock	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viatris	3 Very Positive mention(s)	9 Positive mention(s)	34 Neutral mention(s)	5 Negative mention(s)	3 Very Negative mention(s)	Neutral

Do analysts recommend SRRK or VTRS?

Scholar Rock currently has a consensus target price of $42.67, indicating a potential upside of 43.37%. Viatris has a consensus target price of $10.50, indicating a potential upside of 42.08%. Given Scholar Rock's stronger consensus rating and higher probable upside, analysts plainly believe Scholar Rock is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scholar Rock	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Viatris	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Do institutionals & insiders hold more shares of SRRK or VTRS?

91.1% of Scholar Rock shares are owned by institutional investors. Comparatively, 79.9% of Viatris shares are owned by institutional investors. 19.2% of Scholar Rock shares are owned by company insiders. Comparatively, 0.1% of Viatris shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Is SRRK or VTRS more profitable?

Scholar Rock has a net margin of 0.00% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat Scholar Rock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scholar Rock	N/A	-145.60%	-91.83%
Viatris	-5.87%	16.46%	7.09%

Does the MarketBeat Community believe in SRRK or VTRS?

Scholar Rock received 146 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 66.27% of users gave Scholar Rock an outperform vote while only 34.85% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
Scholar Rock	Outperform Votes 169 66.27%	Underperform Votes 86 33.73%
Viatris	Outperform Votes 23 34.85%	Underperform Votes 43 65.15%

Summary

Scholar Rock beats Viatris on 10 of the 18 factors compared between the two stocks.